Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
98-92-0
Molecular formula
C6H6N2O
Molecular weight
122.1246 g/mol
Drug class
Vitamin B3 (niacinamide)water-soluble vitamin and NAD/NADP precursor
Mechanism of action
Serves as a precursor for nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), coenzymes required for redox metabolism, energy production, DNA repair and cellular signalling.
Indications / reported uses
Prevention and treatment of niacin deficiency and pellagra
Use in other dermatological or metabolic conditions is formulation- and evidence-specific and should not be inferred from the vitamin’s biochemical role alone
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Nicotinamide PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Nicotinamide Permitted Daily Exposure (PDE) report (the Nicotinamide PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Nicotinamide Occupational Exposure Limit (OEL) report (the Nicotinamide OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.